Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Nov 06, 2023

BUY
$11.72 - $22.64 $8,754 - $16,912
747 Added 48.35%
2,292 $7.91 Million
Q1 2019

Nov 06, 2023

BUY
$15.12 - $20.28 $2,268 - $3,042
150 Added 10.75%
1,545 $7.83 Million
Q4 2018

Nov 06, 2023

BUY
$14.12 - $23.68 $19,697 - $33,033
1,395 New
1,395 $5.04 Million
Q3 2018

Nov 06, 2023

SELL
$23.24 - $37.32 $28,352 - $45,530
-1,220 Closed
0 $0
Q4 2017

Nov 06, 2023

BUY
$18.24 - $34.68 $22,252 - $42,309
1,220 New
1,220 $9.82 Million
Q3 2017

Nov 06, 2023

SELL
$22.56 - $36.92 $24,500 - $40,095
-1,086 Closed
0 $0
Q2 2017

Nov 06, 2023

BUY
N/A
1,086 New
1,086 $11.7 Million
Q1 2017

Nov 06, 2023

SELL
N/A
-668 Closed
0 $0
Q2 2016

Nov 06, 2023

BUY
N/A
668
668 $13.1 Million

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $44.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.